141 related articles for article (PubMed ID: 30423633)
1. [Progress of liquid biopsy technique and clinical application in lung cancer].
Wang NF; Yang Y; Chen SF
Zhonghua Jie He He Hu Xi Za Zhi; 2018 Nov; 41(11):881-883. PubMed ID: 30423633
[No Abstract] [Full Text] [Related]
2. Liquid biopsies to optimize therapeutic efficacy in unresponsive lung cancer patients.
Santarpia M; Funel N; Ali A; Giovannetti E
Expert Opin Drug Metab Toxicol; 2018 Aug; 14(8):761-763. PubMed ID: 29933706
[No Abstract] [Full Text] [Related]
3. Detection of Discrepant Driver Mutations in a Patient with Two Synchronous Primary Non-Small Cell Lung Cancers (NSCLCs) with Liquid Biopsy.
Lakis S; Heukamp LC; Griesinger F
J Thorac Oncol; 2017 Nov; 12(11):e186-e188. PubMed ID: 29074212
[No Abstract] [Full Text] [Related]
4. Circulating cell-free nucleic acids and platelets as a liquid biopsy in the provision of personalized therapy for lung cancer patients.
Sorber L; Zwaenepoel K; Deschoolmeester V; Van Schil PE; Van Meerbeeck J; Lardon F; Rolfo C; Pauwels P
Lung Cancer; 2017 May; 107():100-107. PubMed ID: 27180141
[TBL] [Abstract][Full Text] [Related]
5. Liquid Biopsy Promotes Non-Small Cell Lung Cancer Precision Therapy.
Lu J; Han B
Technol Cancer Res Treat; 2018 Jan; 17():1533033818801809. PubMed ID: 30244652
[TBL] [Abstract][Full Text] [Related]
6. Evolving use of liquid biopsy in non-small-cell-lung cancer patients.
Indraccolo S
Int J Biol Markers; 2020 Feb; 35(1_suppl):23-25. PubMed ID: 32079459
[TBL] [Abstract][Full Text] [Related]
7. Integrating minimal residual disease monitoring into clinical practice for NSCLC: Is the era upon us?
Li Z; Lu S
Cancer Cell; 2023 Oct; 41(10):1699-1701. PubMed ID: 37816330
[TBL] [Abstract][Full Text] [Related]
8. The liquid biopsy: a tool for a combined diagnostic and theranostic approach for care of a patient with late-stage lung carcinoma presenting with bilateral ocular metastases.
Bouhlel L; Hofman V; Maschi C; Ilié M; Allégra M; Marquette CH; Audigier-Valette C; Thariat J; Hofman P
Expert Rev Anticancer Ther; 2017 Dec; 17(12):1087-1092. PubMed ID: 29069959
[TBL] [Abstract][Full Text] [Related]
9. [Differential lung cancer diagnosis--progress or fiasco?].
Müller KM
Fortschr Med; 1990 Apr; 108(11):17-9. PubMed ID: 2162802
[No Abstract] [Full Text] [Related]
10. Liquid Biopsy, Diagnostic Imaging, and Future Synergies.
Petranovic M; Raoof S; Digumarthy SR; Sharma A; Shepard JO; Gainor JF; Pandharipande PV
J Am Coll Radiol; 2022 Feb; 19(2 Pt B):336-343. PubMed ID: 35152958
[TBL] [Abstract][Full Text] [Related]
11. Lung Cancer Patients with Germline Mutations Detected by Next-Generation Sequencing and/or Liquid Biopsy.
Shukuya T; Patel S; Shane-Carson K; He K; Bertino EM; Shilo K; Otterson GA; Carbone DP
J Thorac Oncol; 2018 Feb; 13(2):e17-e19. PubMed ID: 28989037
[No Abstract] [Full Text] [Related]
12. Utility of Liquid Biopsy by Improved PNA-LNA PCR Clamp Method for Detecting EGFR Mutation at Initial Diagnosis of Non-Small-Cell Lung Cancer: Observational Study of 190 Consecutive Cases in Clinical Practice.
Ito K; Suzuki Y; Saiki H; Sakaguchi T; Hayashi K; Nishii Y; Watanabe F; Hataji O
Clin Lung Cancer; 2018 Mar; 19(2):181-190. PubMed ID: 29174086
[TBL] [Abstract][Full Text] [Related]
13. Liquid biopsy in non-small cell lung cancer: Is it ready for prime time yet?
Shrestha DP; Lee DJ; Kao AS
Asia Pac J Clin Oncol; 2023 Apr; 19(2):e3-e4. PubMed ID: 35634802
[No Abstract] [Full Text] [Related]
14. The role of the percutaneous biopsy in the evolving diagnosis and treatment of lung cancer.
Barnes D; Souza C; Entwisle J
Clin Radiol; 2010 Nov; 65(11):951-2. PubMed ID: 20933653
[No Abstract] [Full Text] [Related]
15. Update on EGFR Mutational Testing and the Potential of Noninvasive Liquid Biopsy in Non-Small-cell Lung Cancer.
Kim E; Feldman R; Wistuba II
Clin Lung Cancer; 2018 Mar; 19(2):105-114. PubMed ID: 28935493
[TBL] [Abstract][Full Text] [Related]
16. Dual occurrence of ALK G1202R solvent front mutation and small cell lung cancer transformation as resistance mechanisms to second generation ALK inhibitors without prior exposure to crizotinib. Pitfall of solely relying on liquid re-biopsy?
Ou SI; Lee TK; Young L; Fernandez-Rocha MY; Pavlick D; Schrock AB; Zhu VW; Milliken J; Ali SM; Gitlitz BJ
Lung Cancer; 2017 Apr; 106():110-114. PubMed ID: 28285684
[TBL] [Abstract][Full Text] [Related]
17. Navigating into a stormy sea: liquid biopsy enters peri-operative management in early-stage non-small cell lung cancer.
Rolfo C; Russo A
Ann Oncol; 2024 Feb; 35(2):147-149. PubMed ID: 38331558
[No Abstract] [Full Text] [Related]
18. Exosomes as a liquid biopsy for lung cancer.
Cui S; Cheng Z; Qin W; Jiang L
Lung Cancer; 2018 Feb; 116():46-54. PubMed ID: 29413050
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of transbronchial needle aspiration in evaluating patients with lung cancer.
Gasparini S; Silvestri GA
Thorax; 2005 Nov; 60(11):890-1. PubMed ID: 16263944
[No Abstract] [Full Text] [Related]
20. Liquid biopsy in non-small cell lung cancer: a key role in the future of personalized medicine?
Pi C; Zhang MF; Peng XX; Zhang YC; Xu CR; Zhou Q
Expert Rev Mol Diagn; 2017 Dec; 17(12):1089-1096. PubMed ID: 29057681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
